Navigation Links
Vermillion Announces First Quarter 2008 Financial Results and Business Progress
Date:5/15/2008

- Company Focused on Commercialization in 2008 -

FREMONT, Calif., May 15 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML), a molecular diagnostics company, today announced financial results for the first quarter ended March 31, 2008, and provided an update on recent corporate and clinical developments.

"During the first quarter of 2008, we demonstrated significant clinical and commercialization progress in each of our diagnostic programs. These programs target significant unmet clinical needs and present attractive revenue opportunities. It is an exciting time as we explore strategic business development options that are synergistic with our Quest Diagnostics' alliance," said Gail Page, President and CEO of Vermillion.

The Company plans to finalize its clinical study examining the Ovarian Tumor Triage Test, now named OVA1(TM), and submit OVA1 to the U.S. Food and Drug Administration (FDA) in the second quarter of this year. Additionally, Vermillion is working on clinical studies and building market awareness of the PAD blood test, now named VASCLIR(TM) the PAD test. Throughout the remainder of 2008, the Company will focus on commercialization efforts.

First Quarter 2008 Financial Results

As a result of the November 13, 2006 sale of its former instrument business to Bio-Rad Laboratories, the Company does not anticipate significant revenue until its diagnostic tests are commercialized. During the first quarter of 2008, products revenue of $5,000 was generated from the sale of thrombotic thrombocytopenic purpura ("TTP") test component materials to The Ohio State University Research Foundation ("OSU").

Total operating expenses decreased in the first quarter of 2008 to $4.6 million,
'/>"/>

SOURCE Vermillion, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Vermillion and Collaborators Discover Protein Biomarker Associated with Peripheral Artery Disease
3. Vermillion, Inc. Announces Receipt Of Notice Of Compliance From Nasdaq
4. Vermillion to Webcast Presentation at the Acumen BioFin 9th Annual Healthcare Conference, November 5-7, New York
5. Vermillion and Johns Hopkins Sign Collaborative Research and License Agreements to Develop Molecular Diagnostic Tests
6. Vermillion Receives NASDAQ Notice of Non-Compliance
7. Vermillion and Stanford University Sign Exclusive License Agreement for Novel Biomarker Panel to Assess Peripheral Artery Disease Risk
8. Vermillion Announces Effectiveness of Reverse Stock Split
9. Vermillion Summarizes Recent Accomplishments and 2007 Financial Results; Outlines 2008 Business Milestones
10. Vermillion Meets Minimum Bid Price and Receives NASDAQ Staff Determination Letter for Minimum Market Capitalization
11. Vermillion Biomarker Panel Potential Aid in the Diagnosis of Peripheral Artery Disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...rk investment bank KTA Capital,s client Neuren Pha...l convertible note private placement with a U.S. i...rranged by KTA Capital as Neuren,s exclusive place... New York (PRWEB) November 23, 2009 -- The indepen...uot;KTA Capital") has announced that its clie...
(Date:11/24/2009)...re employment grew by 29,000 jobs in October, and... growth during the U.S. recession. However, clinic...ealth systems are coming closer to having to actua...trators. , (Vocus) Novemb...owing in October despite the shedding of jobs in m...
(Date:11/24/2009)...wire/ -- Blue Marble Energy Corp. announced today ... Authority (OPDA) were recently awarded $2 million...zation Board (CERB) in a private/public partnershi...ical biorefinery in Lincoln County, WA. ,, "T...pment of our biorefinery and bring over 70 green j...
(Date:11/24/2009)...2009 Arena Pharmaceutica...he company is scheduled to present at the Piper Ja...er 1, 2009 at 11:30 a.m. Eastern Time (8:30 a.m. P...ork City. Jack Lief, Arena,s President and Chief E...iew of the company, including its clinical develop...
Breaking Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 3
...ry 27 Debiopharm Group,(Debiopharm), a global ind...focusing on serious medical conditions and particu...of a Debiopharm oncology chair at the Ecole,Polyte...ignal Transduction,in Oncogenesis. Funded through ...chair is to leverage the wide scope of ideas and i...
...rchase Agreement Entered Into Between Genmab, an...DL,s Manufacturing Facility has Rece... Genmab A/S (OMX: GEN),announced today that the p...PDL BioPharma, Inc. under which Genmab would acqui...ved antitrust clearance from the US,antitrust auth...
...es Leading Mobile Computing Workstations with Un... with Patients, COLUMBUS, Ohio, Feb. 26 Artromic...d healthcare technology solutions for the,long-ter...sive referral,agreement with McKesson Automation, ...healthcare services, automation and information te...
Other Biology Technology:Debiopharm and EPFL Establish an Oncology Chair 2Purchase Agreement for Antibody Manufacturing Facility Receives Antitrust Clearance 2Artromick Aligns with McKesson to Enhance Medication Safety at the Patient's Bedside 2Artromick Aligns with McKesson to Enhance Medication Safety at the Patient's Bedside 3
(Date:11/26/2009)...are the bare essentials of life, the indispensable...urvive on its own? Can we describe the molecular a...anism functions as a system? These are just some o...etween the European Molecular Biology Laboratory (...gulacio Genmica (CRG) in Barcelona, Spain, set out...
(Date:11/25/2009)...fficers and ambulance workers faced a terrifying r...ey battled to save people from the collapsing Twin... evacuated as many people as they could in an area...aking their jobs even harder was the problem of po...latives jammed mobile networks with calls and the ...
(Date:11/25/2009)...as vital to your health as what you eat, found res...ies. Their experiments in mice revealed that the d...e liverthe body,s metabolic clearinghouseis mostly...ircadian clock as conventional wisdom had it. , ...ge number of genes completely independent of the c...
Breaking Biology News(10 mins):First-ever blueprint of a minimal cell is more complex than expected 2First-ever blueprint of a minimal cell is more complex than expected 3Magic box for mission impossible 2Magic box for mission impossible 3Feeding the clock 2Feeding the clock 3CryoLife to Present at Upcoming Investor Conferences in New York 6166 1CryoLife to Present at Upcoming Investor Conferences in New York 6166 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 6161 1Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 6161 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 6161 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in North America 6161 4Aware Inc Announces Support for New ITU Testing Standard with Line Diagnostics Platform 10688 1Aware Inc Announces Support for New ITU Testing Standard with Line Diagnostics Platform 10688 2Aware Inc Announces Support for New ITU Testing Standard with Line Diagnostics Platform 10688 3Aware Inc Announces Support for New ITU Testing Standard with Line Diagnostics Platform 10688 4
...choanoflagellates have in common? More than you,d ...me shows these ancient organisms have similar leve...s, including humans, use to communicate with each ... in the Proceedings of the National Academies of ...llates, role as an evolutionary link between singl...
...rkinson,s Disease Foundation (PDF) is pleased to a...ternational Research Grants and Fellowship Program...f 19 Parkinson,s scientists, chosen on April 11 fr...c review committee led by Stanley Fahn, M.D., PDF,... awardees, who hail from around the world, include...
...evokes memories of promising spring days and visio...been well-loved staples in America,s yards and gar...ry. , Native to East Asia and Southeast Europe, l...ettlers and were sold in American nurseries as ear...ica may be those at the Governor Wentworth estate ...
Other Biology News:Crossed (evolutionary) signals? 2Crossed (evolutionary) signals? 3The Parkinson's Disease Foundation awards $950,000 in seed grants 2The Parkinson's Disease Foundation awards $950,000 in seed grants 3Patriotic new lilacs introduced 2
...uses a simplified procedure and streamlines the bi...it is based on the three step reaction that takes ...cytosine is converted into uracil. The EZ DNA Meth...eaction eliminates several precipitation steps and...
...ys are intended for laboratory research use only. ...ered formalin and embedded in paraffin. Tissue id...ied pathologists. Tissue cores were removed from ...ipient paraffin block, in an array pattern, using ...
...ys are intended for laboratory research use only. ...ered formalin and embedded in paraffin. Tissue id...ied pathologists. Tissue cores were removed from ...ipient paraffin block, in an array pattern, using ...
...issue extracts (liver, kidney, spleen, and heart) ...so tested with microsomal fractions prepared from ...and reliable method for measuring NDPase activity ...f the inorganic phosphate released from NDP by the...
Biology Products: